$CROX

Crocs 3Q 2026: Revenue $1.04B, Net income $216.76M, EPS $4.52— 10-Q Summary

Crocs reported Q3 2026 revenue of $1.04B, up 4.6% YoY, with net income rising 48.6% to $216.76M and EPS increasing 67.4% to $4.52. Growth was driven by higher unit sales and improved average selling prices, particularly in the Crocs and HEYDUDE brands. The company is focusing on North American growth and digital capabilities.

Original reporting
Published Oct 29, 2026, 4:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 4:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Crocs 3Q 2026: Revenue $1.04B, Net income $216.76M, EPS $4.52— 10-Q Summary — source image
Decision brief

The 30-second read

$CROXBullishHigh
01

Why it matters

Fresh earnings data provide a clear catalyst for short‑term price movement and inform longer‑term valuation.

02

Market read

First‑report earnings release for a mid‑cap consumer discretionary stock, likely to move the ticker in after‑hours trading.

03

What to watch

Supply‑chain constraints or higher input costs could pressure future margins despite current gains.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

The article is an AI‑generated summary of Crocs' Form 10‑Q filing for Q3 2026.

Company-level read

Ticker impact

$CROXBullishHigh confidence
Context

Crocs reported Q3 2026 revenue of $1.04B, net income $216.76M and EPS $4.52, beating prior-year growth rates.

Expected impact

potential upward pressure as investors price in better-than-expected earnings and margin expansion

Evidence & confidence

The company posted strong top‑line growth, a 48.6% jump in net income and a 770‑bp margin expansion, which are likely to be viewed favorably by the market.

Market effects

Footwear and apparel sector may see a modest lift as Crocs demonstrates demand resilience.

North American consumer spending outlook is reinforced by Crocs' growth.

Limited to U.S. consumer discretionary investors; no broad macro impact.

Counterpoint

If the earnings beat is already priced in, the stock could face a short‑term pullback.

Key entities

  • Crocs, Inc.

    Footwear and apparel manufacturer listed on NYSE under ticker CROX.

Related articles

$CROXMed

UBS raises Crocs stock price target to $145 on strong results

UBS raised its price target on Crocs (CROX) to $145 from $120, citing strong Q3 results and raised guidance. The stock has surged 26% in a week. UBS noted macro uncertainty but sees balanced risk. Crocs reported adjusted earnings of $3.69 per share and revenue of $1.04B, exceeding expectations. Goldman Sachs also raised its target to $128 but maintained a Sell rating.

$CROXMed

Goldman Sachs raises Crocs stock price target on growth outlook

Goldman Sachs raised its price target on Crocs (CROX) to $128 from $95, citing stronger growth, improved profitability, and a positive outlook. The stock has surged 75.7% year-to-date. Crocs reported stronger-than-expected Q3 results, with adjusted earnings of $3.69 per share and revenue of $1.04 billion, raising its full-year outlook. The HEYDUDE brand showed positive performance after two years of negative results.

$CROXHighAI 9/10

"I thought ugly shoes were a thing of the past"... Crocs shares stage stunning turnaround after plunging 30%

Crocs shares surged 25.54% to $150.26 after strong Q3 results and an upgraded full-year outlook. Adjusted EPS of $3.69 beat estimates, and revenue reached $1.04 billion. HEYDUDE, a subsidiary, saw a 6.1% revenue increase. CEO Andrew Rees cited growth across brands and regions. Last year, shares plunged 30% due to weak guidance and market trends.